Kumamoto, Japan

Ken Okumura


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ken Okumura: Innovator Behind Long-Acting Coronary Blood Vessel Dilation

Introduction

Ken Okumura, an innovative inventor based in Kumamoto, Japan, has made significant contributions to the field of pharmacology through his research and development efforts at Dojindo Laboratories. With one patent to his name, he has pioneered a novel approach to coronary blood vessel dilation that presents promising therapeutic applications.

Latest Patents

Okumura's patent focuses on Imidazolinoxyl derivatives, which are defined by a specific general formula. These compounds are designed to exhibit long-acting effects in dilating coronary blood vessels. Notably, one of the compounds features a carboxylic acid (COOH) group represented as compound A, demonstrating significant potential in achieving relaxation and dilation of blood vessels when administered in appropriate concentrations.

Career Highlights

Throughout his career at Dojindo Laboratories, Ken Okumura has established himself as a leading figure in the development of innovative pharmaceutical compounds. His work emphasizes the creation of Imidazolinoxyl derivatives that provide a significant and enduring relaxing action on blood vessels, a breakthrough that could transform treatment methodologies for cardiovascular ailments. Okumura has focused on ensuring that these compounds exhibit minimal side effects and are quickly excreted from the system, enhancing patient safety during treatment.

Collaborations

In his pursuit of innovation, Ken Okumura has collaborated with esteemed colleagues such as Ryusuke Tsunoda and Hiroshi Maeda. Their combined expertise fosters an environment of creativity and technical advancement, further propelling the research projects at Dojindo Laboratories and contributing to the success of Okumura's patent.

Conclusion

Ken Okumura exemplifies the spirit of innovation within the pharmaceutical field, demonstrating how targeted research can lead to impactful inventions. His patent on Imidazolinoxyl derivatives not only showcases his ingenuity but also opens new avenues for the treatment of coronary health issues. With continued collaborations and research, Okumura is poised to make even more significant contributions to medical science in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…